Fibrinogen human Completed Phase 3 Trials for Blood Loss / Hip Fracture Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02150720Prevention of Postoperative Bleeding in Subcapital Femoral Fractures